-
1
-
-
0033772093
-
Gastrointestinal Stromal tumors: Current diagnosis, biologic behavior, and management
-
Pidhorecky I, Cheney RT, Kraybill WG, et al. Gastrointestinal Stromal tumors: current diagnosis, biologic behavior, and management. J Surg Onc 2000;7:705-712.
-
(2000)
J Surg Onc
, vol.7
, pp. 705-712
-
-
Pidhorecky, I.1
Cheney, R.T.2
Kraybill, W.G.3
-
2
-
-
0033984319
-
Two hundred gastrointestinal stromal tumors: Recurrence patterns and prognostic factors for survival
-
DeMatteo RP, Lewis JJ, Leung DL, et al. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg 2000;231:51-58.
-
(2000)
Ann Surg
, vol.231
, pp. 51-58
-
-
DeMatteo, R.P.1
Lewis, J.J.2
Leung, D.L.3
-
3
-
-
0026543276
-
Prognostic implications of patterns of failure for gastrointestinal leiomyosarcomas
-
Ng E-H, Pollock RE, Romsdahl MM. Prognostic implications of patterns of failure for gastrointestinal leiomyosarcomas. Cancer 1992;69:1334-1341.
-
(1992)
Cancer
, vol.69
, pp. 1334-1341
-
-
Ng, E.-H.1
Pollock, R.E.2
Romsdahl, M.M.3
-
4
-
-
0036227930
-
Cutaneous metastases from a gastrointestinal stromal tumor of the stomach: Review of the literature
-
Shabahang M, Livingstone AS. Cutaneous metastases from a gastrointestinal stromal tumor of the stomach: review of the literature. Dig Surg 2002;19:64-65.
-
(2002)
Dig Surg
, vol.19
, pp. 64-65
-
-
Shabahang, M.1
Livingstone, A.S.2
-
5
-
-
0031115059
-
Needle tract recurrences after closed biopsy or sarcoma: Three cases and review of the literature
-
Schwartz S, Spengler D. Needle tract recurrences after closed biopsy or sarcoma: Three cases and review of the literature. Ann Surg Onc 1997;4:228-236.
-
(1997)
Ann Surg Onc
, vol.4
, pp. 228-236
-
-
Schwartz, S.1
Spengler, D.2
-
6
-
-
0036334293
-
Port site metastasis after diagnostic laparoscopy for upper gastrointestinal tract malignancies: An uncommon entity
-
Shoup M, Brennan MF, Karpeh MS, et al. Port site metastasis after diagnostic laparoscopy for upper gastrointestinal tract malignancies: an uncommon entity. Ann Surg Onc 2002;9:632-636.
-
(2002)
Ann Surg Onc
, vol.9
, pp. 632-636
-
-
Shoup, M.1
Brennan, M.F.2
Karpeh, M.S.3
-
7
-
-
0029803494
-
Port-site metastases in patients undergoing laparoscopy for gastrointestinal malignancy
-
Cook TA, Dehn TCB. Port-site metastases in patients undergoing laparoscopy for gastrointestinal malignancy. BJS 1996;83:1419-1420.
-
(1996)
BJS
, vol.83
, pp. 1419-1420
-
-
Cook, T.A.1
Dehn, T.C.B.2
-
8
-
-
0028318450
-
Abdominal wall metastases following laparoscopy
-
Nduka CC, Monson JRT, Menzies-Gow N, et al. Abdominal wall metastases following laparoscopy. BJS 1994;81:648-652.
-
(1994)
BJS
, vol.81
, pp. 648-652
-
-
Nduka, C.C.1
Monson, J.R.T.2
Menzies-Gow, N.3
-
9
-
-
15644363454
-
Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors
-
Hirota S, Isozaki K, Moriyama Y, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998;279:577-580.
-
(1998)
Science
, vol.279
, pp. 577-580
-
-
Hirota, S.1
Isozaki, K.2
Moriyama, Y.3
-
10
-
-
0032408616
-
KIT mutation portends poor prognosis in gastrointestinal stromal/smooth muscle tumors
-
Ernst SI, Hubs AE, Przygodzki RM, et al. KIT mutation portends poor prognosis in gastrointestinal stromal/smooth muscle tumors. Lab Invest 1998;78:1633-1636.
-
(1998)
Lab Invest
, vol.78
, pp. 1633-1636
-
-
Ernst, S.I.1
Hubs, A.E.2
Przygodzki, R.M.3
-
11
-
-
0037186924
-
Imatinib mesylate: A new oral targeted therapy
-
Savage DG, Antman KH. Imatinib mesylate: a new oral targeted therapy. NEJM 2002;346:683-693.
-
(2002)
NEJM
, vol.346
, pp. 683-693
-
-
Savage, D.G.1
Antman, K.H.2
-
12
-
-
0037103424
-
Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors
-
Demitri GD, von Mehren M, Blanke CD, et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. NEJM 2002;347:472-480.
-
(2002)
NEJM
, vol.347
, pp. 472-480
-
-
Demitri, G.D.1
Von Mehren, M.2
Blanke, C.D.3
-
13
-
-
0036841799
-
The GIST of targeted therapy: A tumor (gastrointestinal stromal tumor), a mutated gene (c-kit), and a molecular inhibitor (STI571)
-
DeMatteo RP. The GIST of targeted therapy: a tumor (gastrointestinal stromal tumor), a mutated gene (c-kit), and a molecular inhibitor (STI571). Ann Surg Onc 2002;9:831-839.
-
(2002)
Ann Surg Onc
, vol.9
, pp. 831-839
-
-
DeMatteo, R.P.1
-
14
-
-
0035899418
-
STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: Biologic and clinical implications
-
Tuveson DA, Willis NA, Jacks T., et al. STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biologic and clinical implications. Oncogene 2001;20:5054-5058.
-
(2001)
Oncogene
, vol.20
, pp. 5054-5058
-
-
Tuveson, D.A.1
Willis, N.A.2
Jacks, T.3
|